Nigeria was set to receive the antiviral drug Favipiravir from Japan
as a possible Ebola treatment, the Health Ministry said on Monday.
Favipiravir,
developed by the Japanese pharmaceutical company Fujifilm Holdings, was
available for immediate delivery, Health Minister Onyebuchi Chukwu said
during an emergency meeting in the capital, Abuja
The drug was
approved to treat the flu by the Japanese health ministry in March.
Fujifilm Holdings is in talks with the US Food and Drug Administration
to begin clinical testing of Favipiravir as an Ebola treatment.
"It
is shown to have strong antiviral property against the Ebola virus" in
the lab and in patients, the minister said as the Ebola outbreak
continues to accelerate in West Africa with the death toll now estimated
at 1 552, according to the World Health Organization (WHO).
The Geneva-based WHO said 3 069 suspected or confirmed cases had been reported in Guinea, Liberia, Nigeria and Sierra Leone.
Enough dosages of Favipiravir to treat about 20 000 patients were available.
Nigeria also applied for the experimental Ebola drug TKM-Ebola, Chukwu said.
TKM-Ebola
was tested for safety in a small number of humans, but the trial was
halted in January when one volunteer developed moderate gastrointestinal
side effects.
Nigeria also offered to participate in clinical trials for two Ebola vaccines, the health minister said.
Success rate
Success rate
In
Liberia, two Ebola-infected health workers who were treated with the
experimental drug ZMapp have recovered, the health ministry said on
Monday.
A third physician treated there with ZMapp, Abraham Dorbor, died last week.
The
two doctors who recovered, a Nigerian and a Ugandan working in Liberia,
had received ZMapp treatment since 10 August, ministry spokesperson
John Sumo said. They were discharged from a treatment centre in the
capital, Monrovia, at the weekend.
Two US health workers, Kent
Brantly and Nancy Writebol, who had contracted Ebola in Liberia, were
discharged in mid-August from a hospital in Atlanta, where they had been
treated with ZMapp.
Spanish priest Miguel Pajares, however, died
from Ebola in a Madrid hospital after his evacuation from Liberia
despite also receiving ZMapp.
Ebola causes massive haemorrhaging
and is transmitted through contact with blood and other bodily fluids.
If left untreated, it has a fatality rate of up to 90%.
0 komentar:
Post a Comment